Clinical Trials Browser

Phase 2 × Osteosarcoma × avelumab × Clear all

NCT03006848 2026-02-23

A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma

Phase 2 Completed

19 enrolled 11 charts

Osteosarcoma